The integrin alphav beta6 is restricted to epithelial cells and is dramatic
ally induced in response to injury and inflammation. Mice expressing a null
mutation of this integrin develop exaggerated inflammation of the lungs an
d skin, but are dramatically protected from bleomycin-induced pulmonary fib
rosis. This phenotype led to the identification of a unique role for this i
ntegrin in binding to and activating latent extracellular complexes of the
anti-inflammatory, profibrotic cytokine, transforming growth factor-beta (1
). This integrin-mediated activation is tightly spatially restricted and ap
pears to require direct presentation of the activated cytokine to receptors
on adjacent cells. The process also requires distinct regions of the beta6
-subunit cytoplasmic domain and an intact actin cytoskeleton, suggesting th
e existence of additional cellular mechanisms to regulate this process. If
this mechanism is found to be as important in humans as it is in mice, the
integrin and as yet to be identified pathways for cellular regulation of th
is process could be exciting new targets for intervention in fibrotic disea
ses of the lung and other epithelial organs.